Additional Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    Advanced Pulmonary Research Institute
    Loxahatchee FL. 33470
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    NewportNativeMD
    Newport Beach CA. 92663
    View Details

  • A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

    El Paso Pulmonary Association
    El Paso TX. 79902
    View Details

  • PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

    University of Texas Southwestern
    Dallas TX. 75390
    View Details

  • PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

    University of Virginia
    Charlottesville VA. 22908
    View Details

  • PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

    University of Michigan
    Ann Arbor MI. 48109
    View Details

  • PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

    University of Massachusetts Chan Medical School
    Worcester MA. 01655
    View Details

  • Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes

    Duke University Medical Center
    Durham NC. 27710
    View Details

  • Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes

    University of California at San Francisco
    San Francisco CA. 94143
    View Details

  • Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes

    University of Michigan
    Ann Arbor MI. 48109
    View Details

  • A Study of Mosliciguat in PH-ILD

    UCLA Health Westwood Medical Plaza
    Westwood CA. 90095
    View Details

  • A Study of Mosliciguat in PH-ILD

    Summit Health
    Bend OR. 97701
    View Details

  • A Study of Mosliciguat in PH-ILD

    PulmonIx
    Greensboro NC. 27403
    View Details

  • A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.

    Baylor Scott & White Research Institute
    Dallas TX. 75204
    View Details

  • A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.

    Pierre-Le Gardeur
    Québec QC J6V 2H2
    View Details

  • A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.

    Kelowna Respiratory & Allergy Clinic
    Kelowna V1Y 2E1
    View Details

  • A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.

    Laval Hospital
    Laval QC H7M 3L9
    View Details

  • A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.

    Endeavor Health - Evanston Hospital
    Evanston IL. 60201
    View Details

  • A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.

    UAB Hospital, School of Medicine/Lung Health Center
    Birmingham AL. 35294
    View Details

  • A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.

    Cleveland Clinic - Cleveland, Department of Pulmonary Medicine
    Cleveland OH. 44106
    View Details